Published in J Urol on March 01, 2007
Experimental rat bladder urothelial cell carcinoma models. World J Urol (2009) 0.85
Animal models for bladder cancer: The model establishment and evaluation (Review). Oncol Lett (2015) 0.81
Current animal models of bladder cancer: Awareness of translatability (Review). Exp Ther Med (2014) 0.78
Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway. J Korean Med Sci (2014) 0.76
Tumor establishment features of orthotopic murine bladder cancer models. Korean J Urol (2012) 0.75
Insights from animal models of bladder cancer: recent advances, challenges, and opportunities. Oncotarget (2017) 0.75
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med (2002) 3.74
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies. J Am Coll Cardiol (2006) 2.44
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A (2002) 2.27
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med (2009) 2.25
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet (2008) 2.21
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol (2011) 2.10
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation (2009) 1.95
Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model. Circ Res (2003) 1.82
Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs. J Am Coll Cardiol (2006) 1.74
AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol (2010) 1.72
Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol (2009) 1.71
Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med (2002) 1.66
Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation (2010) 1.63
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther (2005) 1.59
Preoperative nomograms for predicting stone-free rate after extracorporeal shock wave lithotripsy. J Urol (2006) 1.59
Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma. Jpn J Clin Oncol (2007) 1.58
Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts. Hypertension (2005) 1.53
Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. Carcinogenesis (2006) 1.49
Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J Control Release (2008) 1.49
Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. Hypertens Res (2007) 1.49
Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer. J Urol (2003) 1.45
An infantile case of Hinman syndrome with severe acute renal failure. Clin Exp Nephrol (2008) 1.42
Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy. Hypertens Res (2006) 1.42
Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients. Pediatr Transplant (2006) 1.41
Use of near-infrared spectroscopy in combination with monitoring of external jugular vein pressure for early detection of cerebral ischemia by unintentional superior vena cava obstruction. J Cardiothorac Vasc Anesth (2012) 1.39
Vaginoplasty in the female exstrophy population: Outcomes and complications. J Pediatr Urol (2010) 1.38
Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis (2003) 1.37
Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP. Jpn J Clin Oncol (2007) 1.34
Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology (2004) 1.34
Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun (2005) 1.33
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. J Urol (2005) 1.31
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation. Am J Physiol Heart Circ Physiol (2002) 1.31
Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg (2007) 1.30
Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema. Ann Plast Surg (2007) 1.25
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate (2007) 1.24
Elevated Akt activation and its impact on clinicopathological features of renal cell carcinoma. J Urol (2003) 1.23
Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. Jpn J Clin Oncol (2004) 1.22
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation (2006) 1.21
Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res (2009) 1.20
An experimental study of the regeneration of the intervertebral disc with an allograft of cultured annulus fibrosus cells using a tissue-engineering method. Spine (Phila Pa 1976) (2003) 1.20
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts. J Mol Cell Cardiol (2008) 1.20
Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol (2004) 1.20
Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis (2006) 1.19
Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs (2004) 1.18
Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res B Appl Biomater (2006) 1.14
Interleukin 6 is associated with cachexia in patients with prostate cancer. Urology (2007) 1.11
Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials (2002) 1.11
IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int (2009) 1.10
Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology (2005) 1.09
Discrimination between normal and malignant human gastric tissues by Fourier transform infrared spectroscopy. Cancer Detect Prev (2004) 1.09
The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol (2003) 1.09
Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res (2003) 1.08
Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials (2004) 1.08
STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P. Kidney Int (2002) 1.04
Medium (DMEM/F12)-containing chitosan hydrogel as adhesive and dressing in autologous skin grafts and accelerator in the healing process. J Biomed Mater Res B Appl Biomater (2006) 1.03
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int (2008) 1.03
Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials (2003) 1.03
Evaluation of intramitochondrial ATP levels identifies G0/G1 switch gene 2 as a positive regulator of oxidative phosphorylation. Proc Natl Acad Sci U S A (2013) 1.02
Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem Biophys Res Commun (2010) 1.01
Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation (2004) 1.01
Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress. Hypertens Res (2008) 1.01
Detection of skin perforators by indocyanine green fluorescence nearly infrared angiography. Plast Reconstr Surg (2008) 1.01
Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res (2003) 1.00
Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A (2003) 1.00
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation (2004) 1.00
Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension (2003) 0.99
Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis. Pathol Int (2007) 0.98
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. Clin Cancer Res (2006) 0.98
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Control Release (2005) 0.97
SN-38 induces cell cycle arrest and apoptosis in human testicular cancer. Eur Urol (2002) 0.97
[A Case of Repetitive Cardiac Arrest due to Coronary Vasospasm after Sugammadex Administration]. Masui (2015) 0.97
Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol (2007) 0.97
Opening of Ca2+-activated K+ channels is involved in ischemic preconditioning in canine hearts. J Mol Cell Cardiol (2004) 0.97
Targeted increase in cerebral blood flow by transcranial near-infrared laser irradiation. Lasers Surg Med (2010) 0.96
The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors. J Urol (2004) 0.96
Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice. Hypertension (2003) 0.95
IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism. Am J Physiol Renal Physiol (2011) 0.95
Lamr1 functional retroposon causes right ventricular dysplasia in mice. Nat Genet (2004) 0.95
Influence of intra-articular neutrophils on the effects of photodynamic therapy for murine MRSA arthritis. Photochem Photobiol (2009) 0.95
Primary carcinoid tumor in a polycystic kidney. Pathol Int (2003) 0.94
Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev (2009) 0.94
Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer (2004) 0.93
The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol (2006) 0.92
The effect of chitosan hydrogel containing DMEM/F12 medium on full-thickness skin defects after deep dermal burn. Burns (2007) 0.92
Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction. J Surg Res (2005) 0.92
Limited capability of regional lymph nodes to eradicate metastatic cancer cells. Cancer Res (2004) 0.91
Rabbit model of airway stenosis induced by scraping of the tracheal mucosa. Laryngoscope (2005) 0.91